WASHINGTON — Influential government advisers will debate Friday if there's enough proof that a booster dose of Pfizer's COVID-19 vaccine is safe and effective — the first step toward deciding which ...
WASHINGTON — U.S. health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic. Moderna is seeking Food ...
5monon MSN
Moderna’s work developing seasonal vaccines is ‘risky’ under current FDA, analyst says
The biotech company said the FDA won’t review its flu vaccine, in the latest hit to mRNA development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results